Tricuspid Valve Repair Using Autologous Pericardium Annuloplasty in Adults
AbstractUncorrected functional tricuspid regurgitation can lead to long-term morbidity and mortality. To evaluate our results using autologous pericardium annuloplasty to treat tricuspid regurgitation, we retrospectively reviewed 59 consecutive adult patients aged 19 years to 83 years (58.7 ± 15.5 years) who underwent tricuspid valve annuloplasty between 2000 and 2003. Concomitant procedures consisted of mitral valve surgery in 83% of patients, aortic valve surgery in 28%, coronary bypass in 31%, and atrial-septal defect correction in 28%. Annuloplasty was performed using a strip of pericardium treated in glutaraldehyde 0.6% for 10 min. Two rows of continuous horizontal mattress Gore-Tex sutures were used to secure the pericardium to the tricuspid annulus. Follow-up was performed in 100% of the patients, and the mean follow-up was 4.4 ± 1.2 years (range, 2.4 to 7 years). Postoperative death within 30 days occurred in 1 of 59 patients (1.6%). None of the patients required reoperation related to tricuspid regurgitation or stenosis. The actuarial survival rate was 98.4% at 7 years after operation. Echocardiography was performed in 58 of 58 surviving patients (100%). Up to 7 years postoperatively, tricuspid regurgitation was trace in 67.2% of patients, mild in 31%, and moderate in 1.8%; there was no occurrence of severe regurgitation on follow-up. Our results indicate that autologous pericardium tricuspid annuloplasty is a useful procedure in patients with moderate or severe tricuspid regurgitation. This procedure provides a durable, reproducible annuloplasty of the tricuspid valve.
Antunes MJ, Girdwood RW. 1983. Tricuspid annuloplasty: a modified technique. Ann Thorac Surg 35:676-8.nBonow RO, Carabello B, de Leon AC, et al. 1998. ACC/AHA guidelines for the management of patients with valvular heart disease. Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Heart Valve Dis 7:672-707.nBradley SM, Sade RM, Crawford FA. 1997. Anticoagulation in children with mechanical valve prostheses. Ann Thorac Surg 64:30-6.nCarpentier A. 1983. Cardiac valve surgery: the "French correction." J Thorac Cardiovasc Surg 86(3):323-37.nChachques J, Vasseur B, Perier P, Balansa J, Chauvaud S, Carpentier A. 1988. A rapid method to stabilize biological material for cardiovascular surgery. N Y Acad Sci 529:184-6.nCohn LH. 1994. Tricuspid regurgitation secondary to mitral valve disease: when and how to repair. J Card Surg 9: 237-41.nCosgrove DM 3rd, Arcidi JM, Rodriguez L, Stewart WJ, Powell K, Thomas JD. 1995. Initial experience with the Cosgrove-Edwards Annuloplasty System. Ann Thorac Surg 60:499-503.nDe La Zerda DJ, Cohen O, Fishbein MC, et al. 2007. Aortic valve-sparing repair with autologous pericardial leaflet extension has a greater early re-operation rate in congenital versus acquired valve disease. Eur J Cardiothorac Surg 31:256-60.nDe Vega NG, De Rabago G, Castillon L, Moreno T, Azpitarte J. 1973. A new tricuspid repair: short-term clinical results in 23 cases. J Cardiovasc Surg 14:384-6.nDreyfus GD, Corbi PJ, Chan KM, Bahrami T. 2005. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg 79:127-32.nEdmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller C, Weisel R. 1996. Guidelines for reporting morbidity and mortality after cardiac valvular operations. J Thorac Cardiovasc Surg 112:708-11.nFilsoufi F, Anyanwu AC, Salzberg SP, Frankel T, Cohen LH, Adams DH. 2005. Long-term outcomes of tricuspid valve replacement in the current era. Ann Thorac Surg 80:845-50.nFilsoufi F, Salzberg SP, Abascal V, Adams DH. 2006. Surgical management of functional tricuspid regurgitation with a new remodeling annuloplasty ring. Mt Sinai J Med 73:874-9.nKing RM, Schaff HV, Danielson GK, et al. 1984. Surgery for tricuspid regurgitation late after mitral valve replacement. Circulation 70:I193-7.nKuduvalli M, Ghotkar SV, Grayson AD, Fabri BM. 2006. Edge-to-edge technique for mitral valve repair: medium-term results with echocardiographic follow-up. Ann Thorac Surg 82:1356-61.nMatsuyama K, Matsumoto M, Sugita T, et al. 2001. De Vega annuloplasty and Carpentier-Edwards ring annuloplasty for secondary tricuspid regurgitation. J Heart Valve Dis 10:520-4.nMcCarthy PM, Bhudia SK, Rajeswaran J, et al. 2004. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg 127:674-85.nMcGee EC, Gillinov AM, Blackstone EH, et al. 2004. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 128:916-24.nNakano S, Kawashima Y, Hirose H, et al. 1988. Evaluation of long-term results of bicuspidalization annuloplasty for functional tricuspid regurgitation. A seventeen-year experience with 133 consecutive patients. J Thorac Cardiovasc Surg 95:340-5.nNath J, Foster E, Heidenreich PA. 2004. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 43:405-9.nOdim J, Laks H, Allada V, Child J, Wilson s, Gjertson D. 2005. Results of aortic valve sparing and restoration with autologous pericardial leaflet extension in congenital heart disease. Ann Thorac Surg 80:647-54.nRivera R, Duran E, Ajuria M. 1985. Carpentier's flexible ring versus De Vega's annuloplasty: a prospective randomized study. J Thorac Cardiovasc Surg 89:196-203.nRobbins RC, Bowman FO, Malm JR. 1988. Cardiac valve replacement in children: a twenty-year series. Ann Thorac Surg 45:56-61nSade RM, Crawford FA, Fyfe DA, Ginn G. 1988. Valves prostheses in children: a reassessment of anticoagulation. J Thorac Cardiovasc Surg 95:553-61.nTang G, David T, Singh S, Maganti M, Armstrong S, Borger M. 2006. Tricuspid valve repair with an annuloplasty ring results in improved long-term outcomes. Circulation 114:I-577-81.nWang J, Liang Y, Hayashi J. 2005. Selective annuloplasty for tricuspid regurgitation in children. Ann Thorac Surg 79:937-41.nYada I, Tani K, Shimono T, Shikano K, Okabe M, Kusagawa M. 1990. Preoperative evaluation and surgical treatment for tricuspid regurgitation associated with acquired valvular heart disease: the Kay-Boyd method vs the Carpentier-Edwards ring method. J Cardiovasc Surg 31:771-7.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).